Thursday, 3 October 2013

In cancer drug battle, both sides appeal to ethics

Andrea Sloan is dying of ovarian cancer. Having exhausted all standard treatment options, her doctors say her best hope now is a new class of cancer drugs called PARP inhibitors.

Source: http://rss.cnn.com/~r/rss/cnn_health/~3/7IMFrlpaCdU/index.html

I found it found here as an example for more info

No comments:

Post a Comment

Note: only a member of this blog may post a comment.